ConductScience.org, home

Paper41482575

The immunology of vitiligo.

Turk MJ and 1 other. Nat Rev Immunol, 2026. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. The immunology of vitiligo. Papers, record 41482575. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41482575

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The immunology of vitiligo.
PubMed
Journal
Nat Rev Immunol
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
2.51, provisional
iCite
Revised in PubMed
2026-10-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Turk MJMary Johttps://orcid.org/0000-0002-9612-8329
2Huang YHYina Hhttps://orcid.org/0000-0002-0125-9351

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
VitiligoMajor topic
MelanocytesMajor topic
Humans
Animals
CD8-Positive T-Lymphocytes
Autoimmune Diseases
Mice
Autoimmunity

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA023108NCI NIH HHSUnited StatesP30CA023108PubMedNIH RePORTER
R01 CA225028NCI NIH HHSUnited StatesR01CA225028PubMedNIH RePORTER
R01 CA254042NCI NIH HHSUnited StatesR01CA254042PubMedNIH RePORTER

Download CSV of grants

References179

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114172076VITILIGO IN A CASE OF VACCINIA VIRUS-TREATED MELANOMA.Cancer1964https://conductscience.org/library/papers/14172076PubMed
224935676Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation.Pigment Cell Melanoma Res2014https://conductscience.org/library/papers/24935676PubMed
323702581Wnt/β-catenin and kit signaling sequentially regulate melanocyte stem cell differentiation in UVB-induced epidermal pigmentation.J Invest Dermatol2013https://conductscience.org/library/papers/23702581PubMed
424107643Comorbidities associated with vitiligo: a ten-year retrospective study.Dermatology2013https://conductscience.org/library/papers/24107643PubMed
519242513Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.J Invest Dermatol2009https://conductscience.org/library/papers/19242513PubMed
616911396Increased tumor necrosis factor alpha (TNF-alpha) and interleukin 1 alpha (IL1-alpha) levels in the lesional skin of patients with nonsegmental vitiligo.Int J Dermatol2006https://conductscience.org/library/papers/16911396PubMed
711511311
Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo.
J Invest Dermatol2001https://conductscience.org/library/papers/11511311PubMed
823251420Transcriptome analysis reveals markers of aberrantly activated innate immunity in vitiligo lesional and non-lesional skin.PLoS One2012https://conductscience.org/library/papers/23251420PubMed
926501224Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab.JAMA Dermatol2016https://conductscience.org/library/papers/26501224PubMed
1029580869Inverse Relationship between Vitiligo-Related Genes and Skin Cancer Risk.J Invest Dermatol2018https://conductscience.org/library/papers/29580869PubMed
1123447019Mutant HSP70 reverses autoimmune depigmentation in vitiligo.Sci Transl Med2013https://conductscience.org/library/papers/23447019PubMed
1237680638Insight into immune profile associated with vitiligo onset and anti-tumoral response in melanoma patients receiving anti-PD-1 immunotherapy.Front Immunol2023https://conductscience.org/library/papers/37680638PubMed
1320175879Reduced skin homing by functional Treg in vitiligo.Pigment Cell Melanoma Res2010https://conductscience.org/library/papers/20175879PubMed
1438439216Topical antibiotics limit depigmentation in a mouse model of vitiligo.Pigment Cell Melanoma Res2024https://conductscience.org/library/papers/38439216PubMed
1517243956Association of vitiligo with HLA-A2: a meta-analysis.J Eur Acad Dermatol Venereol2007https://conductscience.org/library/papers/17243956PubMed
1634179824Resident and circulating memory T cells persist for years in melanoma patients with durable responses to immunotherapy.Nat Cancer2021https://conductscience.org/library/papers/34179824PubMed
1725576595The inducible costimulator augments Tc17 cell responses to self and tumor tissue.J Immunol2015https://conductscience.org/library/papers/25576595PubMed
1822458952A review of the worldwide prevalence of vitiligo in children/adolescents and adults.Int J Dermatol2012https://conductscience.org/library/papers/22458952PubMed
1915728460Regulated folding of tyrosinase in the endoplasmic reticulum demonstrates that misfolded full-length proteins are efficient substrates for class I processing and presentation.J Immunol2005https://conductscience.org/library/papers/15728460PubMed
2030026331Oncogenic BRAFV600E Governs Regulatory T-cell Recruitment during Melanoma Tumorigenesis.Cancer Res2018https://conductscience.org/library/papers/30026331PubMed

See all 179 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42984631Case Report: Dupilumab-associated psoriasiform eruption followed by depigmentation in a patient with prurigo nodularis and Vogt-Koyanagi-Harada disease.Front Immunol2026https://conductscience.org/library/papers/42984631PubMed
42903092Vitiligo onset following anti-inflammatory biological therapy: a scoping review.Front Immunol2026https://conductscience.org/library/papers/42903092PubMed
42857697Oxidative stress in refractory and recurrent vitiligo: from immune amplification mechanisms to potential stratified antioxidant combination therapy.Front Immunol2026https://conductscience.org/library/papers/42857697PubMed
42812837Gut and skin microbiome-metabolome pathways in vitiligo: from dysbiosis to immune activation and melanocyte dysfunction.Front Immunol2026https://conductscience.org/library/papers/42812837PubMed
42801089Hotspots and Emerging Trends in JAK Inhibitor Therapy for Vitiligo: A Bibliometric Analysis (2015-2025).J Inflamm Res2026https://conductscience.org/library/papers/42801089PubMed
42441140CD8+ Tissue-Resident Memory T Cells in Health and Disease.MedComm (2020)2026https://conductscience.org/library/papers/42441140PubMed
42191963IFN-producing myeloid cells mediate photosensitivity.Nat Immunol2026https://conductscience.org/library/papers/42191963PubMed
42144579IL-21 rs2055979 and serum IL-21 levels are associated with both non-segmental and segmental vitiligo in an Iranian cohort.BMC Immunol2026https://conductscience.org/library/papers/42144579PubMed
42123379Lactate Enhances CD8+ T Cell Cytotoxicity Through H3K9la Upregulation to Drive Vitiligo Pathogenesis.Int J Mol Sci2026https://conductscience.org/library/papers/42123379PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41482575

GET https://conductscience.org/api/papers/v1/41482575/references?page=2